產品名稱 | FITC標記的磷酸化毛細血管擴張性共濟失調癥突變蛋白抗體 |
英文名稱 | Anti-phospho-ATM (Tyr170)/FITC |
規(guī)格 | 100ul |
濃度 | 1mg/ml |
價格 | 來電可享受優(yōu)惠 |
英文名稱 Anti-phospho-ATM (Tyr170)/FITC
中文名稱 :FITC標記的磷酸化毛細血管擴張性共濟失調癥突變蛋白抗體
規(guī)格:100ul
說明書 100ul
產品類型磷酸化抗體
研究領域細胞生物 信號轉導 細胞凋亡 細胞周期蛋白 激酶和磷酸酶
抗體來源Rabbit
克隆類型Polyclonal
交叉反應 Human, Mouse, Rat,
產品應用ICC=1:50-200 IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量370kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免疫原KLH conjugated synthesised phosphopeptide derived from human ATM around the phosphorylation site of Tyr170 [SV(p-Y)FR]
亞 型IgG
純化方法affinity purified by Protein A
儲存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Store at -20 °C for one year.
別 名 ATM (Phospho-Tyr170); ATM (Phospho Y170); p-ATM (Tyr170); p-ATM (Y170); A-T mutated; A-T mutated homolog; AT complementation group A; AT complementation group C; AT complementation group D; AT complementation group E; AT mutated; AT protein; AT1; ATA; Ataxia telangiectasia gene mutated in human beings; Ataxia telangiectasia mutated; Ataxia telangiectasia mutated gene; Ataxia telangiectasia mutated homolog (human); Ataxia telangiectasia mutated homolog; ATC; ATD; ATDC; ATE; ATM; ATM_HUMAN; DKFZp781A0353; Human phosphatidylinositol 3 kinase homolog; MGC74674; Serine protein kinase ATM; Serine-protein kinase ATM; Serine/threonine-protein kinase ATM; T cell prolymphocytic leukemia; Tefu; TEL1; TEL1, telomere maintenance 1, homolog; TELO1; Telomere fusion protein; TPLL.